Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age
Clinical trial NCT03698279 · COMPLETED
Trial details
- NCT number
- NCT03698279
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-09
- Primary completion
- 2019-10-16
- Enrollment
- 665
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.